ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 138 filers reported holding ACCELERON PHARMA INC in Q2 2016. The put-call ratio across all filers is 6.11 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $5,224,000 | +241.2% | 140,000 | +133.3% | 1.44% | +57.4% |
Q4 2016 | $1,531,000 | -39.6% | 60,000 | -14.3% | 0.92% | +102.4% |
Q3 2016 | $2,534,000 | +49.1% | 70,000 | +40.0% | 0.45% | -34.6% |
Q2 2016 | $1,699,000 | -14.1% | 50,000 | -33.3% | 0.69% | -4.7% |
Q1 2016 | $1,979,000 | -72.9% | 75,000 | -50.0% | 0.72% | -69.9% |
Q4 2015 | $7,314,000 | +167.0% | 150,000 | +36.4% | 2.41% | +123.5% |
Q3 2015 | $2,739,000 | -42.3% | 110,000 | -26.7% | 1.08% | -28.1% |
Q2 2015 | $4,746,000 | -28.7% | 150,000 | -14.3% | 1.50% | -46.6% |
Q1 2015 | $6,661,000 | -28.8% | 175,000 | -27.1% | 2.80% | -38.0% |
Q4 2014 | $9,350,000 | +1136.8% | 240,000 | +860.0% | 4.52% | +1018.6% |
Q3 2014 | $756,000 | -79.8% | 25,000 | -77.3% | 0.40% | -76.8% |
Q2 2014 | $3,737,000 | – | 110,000 | – | 1.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |